中国生化药物杂志2017,Issue(4) :293-295.DOI:10.3969/j.issn.1005-1678.2017.04.097

应用奥沙利铂联合替吉奥以及吉西他滨联合顺铂方案对晚期三阴性乳腺癌的疗效与不良反应比较

Comparison of efficacy and adverse reactions of oxaliplatin combined with gemcitabine and S-1 combined with cisplatin for advanced three negative breast cancer

白云 陶阳 王崇杰 左文述
中国生化药物杂志2017,Issue(4) :293-295.DOI:10.3969/j.issn.1005-1678.2017.04.097

应用奥沙利铂联合替吉奥以及吉西他滨联合顺铂方案对晚期三阴性乳腺癌的疗效与不良反应比较

Comparison of efficacy and adverse reactions of oxaliplatin combined with gemcitabine and S-1 combined with cisplatin for advanced three negative breast cancer

白云 1陶阳 1王崇杰 1左文述2
扫码查看

作者信息

  • 1. 山东省医学科学院附属医院 外科,山东 济南 250031
  • 2. 山东省肿瘤医院乳腺外科,山东 济南 250117
  • 折叠

摘要

目的 探讨SOX 与GP 两种联合化疗方法对的治疗疗效与用药后的不良反应.方法 将2014年1月~2016年9月前来山东省医学科学院附属医院接受治疗的晚期三阴性乳腺癌患者84 例作为本研究的观察对象,随机分为SOX 组与GP 组,分别给予相应的化疗措施并观察治疗疗效.结果 2 组患者的CR、PR、SD、PD 例数及总有效率比较,P 值分别为0.693、0.637、0649、0.801、0.823;2 组患者腹泻、肝功能损伤、血小板减少、恶心呕吐、神经毒性、贫血、白细胞减少、皮疹、肾毒性、食欲下降发生率比较,P 值分别为0.374、0.629、0.643、0.374、0.645、0.434、0.450、0.693、0.645、0.815.结论 晚期三阴性乳腺癌的标准化疗方案虽仍不能统一,但SOX 方案与GP 方案均安全有效,可用于临床治疗.

Abstract

Objective To investigate the efficacy and adverse reactions of SOX and GP combined with two chemotherapy methods.Methods From January 2014 to September 2016 came to our hospital for treatment of three advanced breast cancer patients with negative 84 cases as the research object of observation,were randomly divided into SOX group and GP group were given chemotherapy measures and clinical observation on the treatment of.Results Two groups of patients with CR,PR,SD,PD,the number of cases and the total effective rate comparison,P values were 0.693,0.637,0649,0.801,0.823; two groups of patients with diarrhea,liver damage,thrombocytopenia,nausea and vomiting,neurotoxicity,anemia,leukopenia,rash,renal toxicity,appetite the incidence rate of decline,P values were 0.374,0.629,0.643,0.374,0.645,0.434,0.450,0.693,0.645,0.815.Conclusion Standard chemotherapy regimens for advanced three negative breast cancer was not uniform,but the SOX and GP regimens are safe and effective,can be used for clinical treatment.

关键词

奥沙利铂/替吉奥/吉西他滨/顺铂/三阴性乳腺癌

Key words

oxaliplatin/tegafur gimeracil oteracil potassium capsule/gemcitabine/cisplatin/triple negative breast cancer

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量7
参考文献量1
段落导航相关论文